EN
HI
Glaxosmithkline Pharmaceuticals share price chart
Glaxosmithkline Pharmaceuticals Share Key Metrics
Volume
59367.00
Market Cap
45192.45 CR
LTQ@LTP
2@2667.70
ATP
2646.33
Var Margin
15.15 %
Circuit Range
2096.2-3144.2
Delivery %
62.12 %
Value
15.71 CR
ASM/GSM
No
Market Lot
1
Summary
GLAXO stock price is ₹2667.7 as of 14 Aug, 2026. The stock intraday movement has stayed between ₹2606.40 and ₹2677.00, while Glaxosmithkline Pharmaceuticals share price 52 week high low is ₹2088.10 & ₹2883.40.
In terms of trading activity, GLAXO share price has recorded a volume of 59,367 shares. The Glaxosmithkline Pharmaceuticals has a market cap of ₹169406034. The stock’s Average Traded Price (ATP) stands at ₹2646.33, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 2 @ ₹2667.70.
The Glaxosmithkline Pharmaceuticals upper circuit limit is ₹3144.20 & The Glaxosmithkline Pharmaceuticals lower circuit limit is ₹2096.20, with a Value of ₹15.71 CR. The Delivery Percentage for the day is 62.12%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Glaxosmithkline Pharmaceuticals Fundamentals
P/E Ratio
41.55
P/B Ratio
17.61
Div. Yield
2.18
Sector P/E
64.16
Sector P/B
3.28
Sec. Div. Yield
0.51
Glaxosmithkline Pharmaceuticals Resistance and Support
Pivot 2608.2
Resistance
First Resistance
2636.9
Second Resistance
2653.6
Third Resistance
2682.3
Support
First Support
2591.5
Second Support
2562.8
Third Support
2546.1
Glaxosmithkline Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Thu Aug 13 2026 | 2620 | 2667.7 | 1.81% | 2677 | 2606.4 |
| Wed Aug 12 2026 | 2601 | 2620.19 | 0.70% | 2624.89 | 2579.5 |
| Tue Aug 11 2026 | 2617 | 2601.89 | 0.03% | 2617 | 2577 |
Glaxosmithkline Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-03 | Quarterly Results |
| 2026-05-13 | Audited Results & Dividend |
| 2026-02-09 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-08-01 | Quarterly Results |
| 2025-05-13 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2025-02-10 | Quarterly Results |
| 2024-10-29 | Quarterly Results & Interim Dividend |
Glaxosmithkline Pharmaceuticals News
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
GlaxoSmithKline Pharmaceuticals seeks shareholder approval for the re-appointment of MD Bhushan Akshikar for a two-year term starting December 2026, with a basic salary up to ₹2.4 crores/month. Also proposes to appoint Ms. Karine J F Natland as a Non-Executive Director, with e-voting from August 14 to September 13, 2026.
Aug 13 2026 13:02:01
GlaxoSmithKline Pharmaceuticals Ltd - 500660 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
GlaxoSmithKline Pharmaceuticals reported robust Q1 FY27 performance with sales growing 15% to Rs.924 cr and net profit increasing 24% to Rs.253 cr. The company emphasized strong growth in its innovation and specialty product portfolio, with new product launches planned.
Aug 06 2026 19:51:20
Read More
Glaxosmithkline Pharmaceuticals Management
| Name | Position |
|---|---|
| Ajay Nadkarni | Company Secretary & Compliance Officer, Vice President – Administration, Real Estate |
| Renu Sud Karnad | Chairperson |
Glaxosmithkline Pharmaceuticals Similar Stocks
Glenmark Pharmaceuticals Ltd.
2320.00
30.00 (1.31%)
Abbott India Ltd.
27620.00
-520.00 (1.85%)
Anthem Biosciences Ltd.
874.90
-3.50 (0.40%)
Gland Pharma Ltd.
2967.60
76.40 (2.64%)
Ipca Laboratories Ltd.
1796.30
29.70 (1.68%)
Ajanta Pharma Ltd.
3614.60
73.60 (2.08%)
Global Health Ltd.
1410.40
16.90 (1.21%)
Emcure Pharmaceuticals Ltd.
2009.60
0.00 (0.00%)
Narayana Hrudayalaya Ltd.
1831.00
-0.30 (0.02%)
Glaxosmithkline Pharmaceuticals FAQs
The Buying Price of Glaxosmithkline Pharmaceuticals share is 2667.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Glaxosmithkline Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Glaxosmithkline Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Glaxosmithkline Pharmaceuticals shares is 41.55. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Glaxosmithkline Pharmaceuticals shares is 17.61. Useful to assess the stock's value relative to its book value.
To assess Glaxosmithkline Pharmaceuticals’s valuation compare Sector P/E, P/B which are 64.16 & 3.28 with sector averages, along with growth rates and financial metrics.
The Market Cap of Glaxosmithkline Pharmaceuticals is 45192.45 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Glaxosmithkline Pharmaceuticals share price is 2883.40 & 2088.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Glaxosmithkline Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
